Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Real-world treatment patterns and clinical outcomes in patients with essential thrombocythemia treated with cytoreductive therapy: A retrospective analysis of electronic health records data

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEvan C. ChenXYXiaoqin YangMOMavis Obeng‐Kusi

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows cytoreductive therapy impacts thrombotic events in essential thrombocythemia, suggesting unmet treatment needs.

Key Points

  • To evaluate treatment patterns and clinical outcomes in essential thrombocythemia patients receiving cytoreductive therapy.
  • Conducted a retrospective analysis using electronic health records from the Mass General Brigham database.
  • Identified adult patients with an ET diagnosis and elevated platelet counts.
  • Analyzed treatment discontinuation, interruptions and clinical outcomes post-cytoreductive therapy.
  • 30.5% of patients experienced at least one ET-related complication after treatment initiation.
  • Most common first-line treatment was hydroxyurea (94.1%).
  • 47.7% of patients experienced treatment interruptions or discontinuations, with significant clinical implications.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d80ehttps://doi.org/10.1182/blood-2025-2837
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical characteristics, disease progression, and vascular events in essential thrombocythemia: A single-center cohort study with long-term follow-up.2025
  2. 2Estimating incident and prevalent essential thrombocythemia patients eligible for cytoreductive therapies in the US and Canada2025
  3. 3Essential thrombocythaemia: A contemporary approach with new drugs on the horizon2024 · 7 citations
  4. 4Impact of essential thrombocythemia on in-hospital outcomes and thrombotic complications in patients hospitalized with COVID-19: A national inpatient sample analysis (2016–2022)2025
  5. 5Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach2024